Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

M. Nicoletto · SciRah

Researcher profile · Semantic Scholar

M. Nicoletto

Share profile

M. Nicoletto — researcher profile on SciRah

h-index: 23
Works: 75
Citations: 2,011

Most-cited papers

Cancer stem cells from epithelial ovarian cancer patients privilege oxidative phosphorylation, and resist glucose deprivation
Anna Pastò, C. Bellio, G. Pilotto, V. Ciminale +10 more
2014OncoTarget273 citations Open access
Semantic Scholar
Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial.
A. du Bois, G. Kristensen, I. Ray-Coquard, A. Reuss +23 more
2016The Lancet Oncology202 citations Open access
Semantic Scholar
Phase III study of valspodar (PSC 833) combined with paclitaxel and carboplatin compared with paclitaxel and carboplatin alone in patients with stage IV or suboptimally debulked stage III epithelial ovarian cancer or primary peritoneal cancer.
C. Lhommé, F. Joly, J. Walker, A. Lissoni +8 more
2008Journal of Clinical Oncology149 citations
Semantic Scholar
Autophagy inhibition reduces chemoresistance and tumorigenic potential of human ovarian cancer stem cells
Anna Pagotto, G. Pilotto, Elena Laura Mazzoldi, M. Nicoletto +3 more
2017Cell Death and Disease138 citations Open access
Semantic Scholar
Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial
M. Friedlander, V. Gebski, E. Gibbs, L. Davies +18 more
2018The Lancet Oncology122 citations Open access
Semantic Scholar
BRCA Mutation Status and Determinant of Outcome in Women with Recurrent Epithelial Ovarian Cancer Treated with Pegylated Liposomal Doxorubicin
T. Safra, L. Borgato, M. Nicoletto, L. Rolnitzky +10 more
2011Molecular Cancer Therapeutics95 citations Open access
Semantic Scholar
BRCA-1 and BRCA-2 mutations as prognostic factors in clinical practice and genetic counselling.
M. Nicoletto, M. Donach, A. De Nicolo, G. Artioli +2 more
2001Cancer Treatment Reviews84 citations
Semantic Scholar
Diagnosis and Treatment of Malignant Pleural Effusion: A Systematic Literature Review and New Approaches
G. Lombardi, F. Zustovich, M. Nicoletto, M. Donach +2 more
2010American Journal of Clinical Oncology81 citations
Semantic Scholar
Chemotherapy plus or minus bevacizumab for platinum-sensitive ovarian cancer patients recurring after a bevacizumab containing first line treatment: The randomized phase 3 trial MITO16B-MaNGO OV2B-ENGOT OV17.
S. Pignata, D. Lorusso, F. Joly, C. Gallo +16 more
201866 citations
Semantic Scholar
Surgical second look in ovarian cancer: a randomized study in patients with laparoscopic complete remission--a Northeastern Oncology Cooperative Group-Ovarian Cancer Cooperative Group Study.
M. Nicoletto, S. Tumolo, R. Talamini, L. Salvagno +16 more
1997Journal of Clinical Oncology58 citations
Semantic Scholar
Adding gemcitabine to paclitaxel/carboplatin combination increases survival in advanced non-small-cell lung cancer: results of a phase II-III study.
A. Paccagnella, F. Oniga, A. Bearz, A. Favaretto +13 more
2006Journal of Clinical Oncology55 citations
Semantic Scholar
Phase II study of pegylated liposomal doxorubicin and oxaliplatin in relapsed advanced ovarian cancer.
M. Nicoletto, C. Falci, D. Pianalto, G. Artioli +6 more
2006Gynecologic Oncology53 citations
Semantic Scholar
A juxtacrine/paracrine loop between C-Kit and stem cell factor promotes cancer stem cell survival in epithelial ovarian cancer
Elena Laura Mazzoldi, S. Pavan, G. Pilotto, Kevin Leone +5 more
2019Cell Death and Disease46 citations Open access
Semantic Scholar
Combined use of biomarkers for detection of ovarian cancer in high-risk women
M. Donach, Yinhua Yu, G. Artioli, G. Banna +4 more
2010Tumor Biology41 citations
Semantic Scholar
Feasibility and outcome of interval debulking surgery (IDS) after carboplatin-paclitaxel-bevacizumab (CPB): A subgroup analysis of the MITO-16A-MaNGO OV2A phase 4 trial.
G. Daniele, D. Lorusso, G. Scambia, S. Cecere +19 more
2017Gynecologic Oncology39 citations
Semantic Scholar
Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer
M. Nicoletto, R. Padrini, F. Galeotti, E. Ferrazzí +5 more
2000Cancer Chemotherapy and Pharmacology35 citations
Semantic Scholar
BRCA mutations and outcome in epithelial ovarian cancer (EOC): experience in ethnically diverse groups.
T. Safra, W. Lai, L. Borgato, M. Nicoletto +5 more
2012Annals of Oncology30 citations Open access
Semantic Scholar
Resistance to glucose starvation as metabolic trait of platinum-resistant human epithelial ovarian cancer cells
Anna Pastò, Anna Pagotto, G. Pilotto, A. De Paoli +8 more
2016OncoTarget29 citations Open access
Semantic Scholar
Diagnostic and prognostic evaluation of fluorodeoxyglucose positron emission tomography/computed tomography and its correlation with serum cancer antigen-125 (CA125) in a large cohort of ovarian cancer patients.
L. Evangelista, M. D. Palma, M. Gregianin, M. Nardin +4 more
2015Journal of the Turkish-German Gynecological Association27 citations Open access
Semantic Scholar
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer.
S. Pignata, G. Scambia, D. Lorusso, U. de Giorgi +27 more
2019Gynecologic Oncology26 citations Open access
Semantic Scholar
Vulvar cancer: prognostic factors.
M. Nicoletto, A. Parenti, P. Del Bianco, G. Lombardi +7 more
2010Anticancer Research25 citations
Semantic Scholar
A Randomized Study of Epithelial Ovarian Cancer: Is Chemotherapy Useful after Complete Remission?
M. Nicoletto, S. Tumolo, C. Falci, M. Donach +7 more
2004International Journal of Medical Sciences25 citations Open access
Semantic Scholar
BAROCCO: A randomized phase II study of weekly paclitaxel vs cediranib-olaparib combination given with continuous or intermittent schedule in patients with recurrent platinum resistant ovarian cancer (PROC)
N. Colombo, M. Nicoletto, P. Panici, G. Tognon +15 more
2019Annals of Oncology24 citations Open access
Semantic Scholar
Intrapleural paclitaxel for malignant pleural effusion from ovarian and breast cancer: a phase II study with pharmacokinetic analysis
G. Lombardi, M. Nicoletto, M. Gusella, P. Fiduccia +5 more
2012Cancer Chemotherapy and Pharmacology20 citations
Semantic Scholar
INOVATYON/ ENGOT-ov5 study: Randomized phase III international study comparing trabectedin/pegylated liposomal doxorubicin (PLD) followed by platinum at progression vs carboplatin/PLD in patients with recurrent ovarian cancer progressing within 6-12 months after last platinum line
N. Colombo, A. Gadducci, J. Sehouli, E. Rulli +167 more
2023British Journal of Cancer19 citations Open access
Semantic Scholar
Health-related quality of life (HRQOL) and patient-centered outcomes with maintenance olaparib compared with placebo following chemotherapy in patients with germline (g) BRCA-mutated (m) platinum-sensitive relapsed serous ovarian cancer (PSR SOC): SOLO2 phase III trial.
M. Friedlander, V. Gebski, E. Gibbs, R. Bloomfield +16 more
201718 citations
Semantic Scholar
965PEvaluation of tumour responses and olaparib efficacy in platinum-sensitive relapsed ovarian cancer (PSROC) patients (pts) with or without measurable disease in the SOLO2 trial (ENGOT Ov-21)
A. Oza, Pierre Combe, J. Ledermann, S. Marschner +13 more
201716 citations Open access
Semantic Scholar
Metformin: a modulator of bevacizumab activity in cancer? A case report
S. Indraccolo, Giovanni Randon, E. Zulato, M. Nardin +4 more
2015Cancer Biology & Therapy16 citations Open access
Semantic Scholar
Correlation between Magnetic Resonance Imaging and Histopathological Tumor Response after Neoadjuvant Chemotherapy in Breast Cancer
M. Nicoletto, D. Nitti, L. Pescarini, F. Corbetti +11 more
2008Tumori16 citations
Semantic Scholar
Characteristics and outcome of BRCA mutated epithelial ovarian cancer patients in Italy: A retrospective multicenter study (MITO 21).
G. Artioli, G. Giannone, G. Valabrega, F. Maggiorotto +15 more
2021Gynecologic Oncology14 citations Open access
Semantic Scholar
Synchronous and Metachronous Breast and Ovarian Cancer: Experience From Two Large Cancer Center
G. Tasca, M. Dieci, Z. Baretta, G. Faggioni +5 more
2020Frontiers in Oncology14 citations Open access
Semantic Scholar
Rare presentation of endometrial carcinoma with singular bone metastasis.
G. Artioli, M. Cassaro, L. Pedrini, Lucia Borgato +4 more
2010European Journal of Cancer Care14 citations Open access
Semantic Scholar
Comparison of the Genomic Profile of Cancer Stem Cells and Their Non-Stem Counterpart: The Case of Ovarian Cancer
Elena Laura Mazzoldi, Anna Pastò, G. Pilotto, S. Minuzzo +7 more
2020Journal of Clinical Medicine11 citations Open access
Semantic Scholar
Trabectedin plus Pegylated Liposomal Doxorubicin: Retrospective Analysis in Heavily Pretreated Platinum-sensitive Ovarian Cancer
M. Nicoletto, A. Baldoni, Alessandra Casarin, Giovanni Randon +7 more
2015Tumori11 citations Open access
Semantic Scholar
PET/CT imaging in gynecologic malignancies: a critical overview of its clinical impact and our retrospective single center analysis.
Maurizia Dalla Palma, M. Gregianin, P. Fiduccia, L. Evangelista +5 more
2012Critical reviews in oncology/hematology11 citations
Semantic Scholar
Phase I-II intraperitoneal mitoxantrone in advanced pretreated ovarian cancer.
M. Nicoletto, R. Padrini, E. Ferrazzí, Ottorino Nascimben +7 more
1993European Journal of Cancer10 citations
Semantic Scholar
Tolerability of PLD/Oxaliplatin Regimen in Recurrent Ovarian Cancer Patients With Previous Fragility to Carboplatin/Paclitaxel Treatment
M. D. Palma, G. Lombardi, M. Donach, L. Borgato +3 more
2011American Journal of Clinical Oncology9 citations
Semantic Scholar
Positive experience of Intraperitoneal Chemotherapy followed by Intravenous Chemotherapy in Heavily Pretreated Patients with Suboptimal Residual Ovarian Cancer and Primary Peritoneal Cancer
M. Nicoletto, Maurizia Dalla Palma, M. Donach, M. Gusella +11 more
2010Tumori8 citations
Semantic Scholar
Family History of Cancer Rather Than p53 Status Predicts Efficacy of Pegylated Liposomal Doxorubicin and Oxaliplatin in Relapsed Ovarian Cancer
M. Nicoletto, R. Bertorelle, L. Borgato, G. D. De Salvo +7 more
2009International Journal of Gynecologic Cancer8 citations Open access
Semantic Scholar
Elderly ovarian cancer: treatment with mitoxantrone-carboplatin.
M. Nicoletto, G. Artioli, M. Donach, V. C. Sileni +11 more
2001Gynecologic Oncology8 citations
Semantic Scholar
A phase II study of pegylated liposomial doxorubicin (PLD) and gemcitabine (G) in the treatment of hepatocellular carcinoma (HCC) not suitable for loco-regional therapy
D. Pastorelli, G. Cartei, F. Zustovich, S. Zovato +5 more
20077 citations
Semantic Scholar
Long-term survival in a randomized study of nonplatinum therapy versus platinum in advanced epithelial ovarian cancer
M. Nicoletto, S. Tumolo, R. Sorio, G. Cima +6 more
2006International Journal of Gynecologic Cancer7 citations Open access
Semantic Scholar
Experience with intraperitoneal alpha-2a interferon.
M. Nicoletto, M. Fiorentino, O. Vinante, A. Prosperi +4 more
1992Oncology7 citations
Semantic Scholar
Analysis of clinical features of ovarian cancer (OC) and breast cancer (BC) among BRCA-mutated (BRCA+) and sporadic (NH) double tumors.
M. Nicoletto, L. Borgato, G. Artioli, A. Perin +11 more
20126 citations
Semantic Scholar
Squamous cell carcinoma of the oral cavity in a woman with a 9-year history of ovarian cancer: is exposure to pegylated liposomal Doxorubicin a factor?
Giovanni Randon, M. Nicoletto, N. Milite, F. Muggia +1 more
2014The Oncologist5 citations Open access
Semantic Scholar
CA125 reference values change in male and postmenopausal female subjects
G. Cartei, F. Cartei, M. Bertin, A. Padoan +3 more
2012Clinical Chemistry and Laboratory Medicine5 citations Open access
Semantic Scholar
Lack of Cardiotoxicity with Liposomal Doxorubicin in an Elderly Case of Ovarian Cancer
M. Nicoletto, M. Donach, L. Borgato, C. Falci +2 more
2007Tumori5 citations
Semantic Scholar
Combined use of urinary UGP and serum CA 125 in the diagnosis of gynecological cancers.
M. Plebani, F. Navaglia, D. Basso, M. de Paoli +3 more
1996Anticancer Research5 citations
Semantic Scholar
Pegylated liposomal doxorubicin (PLD) treatment for recurrent epithelial ovarian cancer (rEOC): Implications of BRCA mutations.
T. Safra, L. Borgato, M. Nicoletto, L. Rolnitzky +6 more
20104 citations
Semantic Scholar
Intraperitoneal Chemotherapy in Patients Pretreated for Ovarian Cancer Matched with Patients Treated with Parenteral Chemotherapy.
M. Nicoletto, Alessandra Casarin, A. Baldoni, E. Rulli +12 more
2016Anticancer Research3 citations Open access
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

G. Artioli×15
Invite
G. Artioli — researcher profile on SciRah
M. Donach×14
Invite
M. Donach — researcher profile on SciRah
L. Borgato×9
Invite
L. Borgato — researcher profile on SciRah
G. Lombardi×7
Invite
G. Lombardi — researcher profile on SciRah

×6

Invite

F. Zustovich — researcher profile on SciRah

Invite

Anna Pastò — researcher profile on SciRah

Invite

G. Pilotto — researcher profile on SciRah

Invite

A. Amadori — researcher profile on SciRah

Invite

S. Pignata — researcher profile on SciRah

Invite

N. Colombo — researcher profile on SciRah

Invite

A. Baldoni — researcher profile on SciRah

S. Indraccolo×4

Invite

S. Indraccolo — researcher profile on SciRah